Abstract
In mesangial IgA glomerulonephritis deterioration of renal function is not uncommon, occurring in about 20% of patients after several years. In this paper we present preliminary results of a therapeutic trial with phenytoin in thirty-three patients affected by this nephropathy. Up to 1 year of follow-up no significant changes in renal function, proteinuria or haematuria were seen. A significant decrease in serum IgA and a normalization of the high polymeric IgA levels frequently found in these patients, were observed at this time. Of seven patients rebiopsied, markedly reduced IgA mesangial deposits were seen in one and disappearance in the other, by immunofluorescence and by electron microscopy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarli, J.A. and Tonder, O.; Effect of antiepilectic drugs on serum and salivary IgA. Scand. J. Immunol. 4:391–396, (1975).
Berger, J., Yaneva, H., Nabarra, B. and Barbanel, C.: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int. 7: 232–241, (1975).
Berger, J., Yaneva, H. and Crosnier, J,: La glomerulonéphrite a dépots mesetngiaux d’IgA: une cause fréquente d’insuffisance rénale terminale. Nouv. Presse Méd. 9: 219–221, (1980).
Droz, D.: Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contr. Nephrol. 2: 150–157, (1976).
Egido, J., Sancho, J., Mampaso, F., Lopez Trascasa, M., Sanchez Crespo, M. and Hernando,L.: A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger’s disease and Schönlein Henoch. Proc. EDTA, vol 17: 660–666, (1980).
Haldorsen, T. and Aarli, J.A.: Immunoglobulin concentrations in first-degree relatives of epileptic patients with drug- induced IgA deficiency. Acta Neurol.Scandinav. 56: 608–612, (1977).
Jarlot-Déchelette, E.: Contribution a 1’étude de la glomerulonéphrite ä dépots mesangiaux d’IgA. Thèse de Médicine. Grenoble 1975.
Lopez Trascasa, M., Egido, J., Sancho, J. and Hernando L.: Evidence of high polymeric IgA levels in serum of patients with Berger’s disease and its modification with phenytoin treatment. Proc. EDTA vol. 16: 513–519, (1979).
Lopez Trascasa, M., Egido, J., Sancho, J. and Hernando L.: IgA glomerulonephritis (Berger’s disease): Evidence of high levels of polymeric IgA. Clin. Exp. Immunol. 42: 247–254, (1980).
Levy, M., Beaufils, H., Gubler, M.C. and Habib, R.: Idiopathic recurrent macroscopic haematuria and mesangial IgA-IgG deposits in children (Berger’s disease), Clin. Nephrol. 2: 63, (1973).
Seager, J., Jamison, D.L., Wilson, J., Hayward, A.R. and Soothill, J.F.: IgA deficiency, epilepsy and Phenytoin treatment. Lancet., 2: 632–635, (1975).
Sorrell, T.C. and Forbes, I.J.: Depression of immune competence by Phenytoin and carbamazepine. Clin. Exp. Immunol. 20: 273–285, (1975).
Van der Feet, J., Arisz, L., Bretjens, J.R.H., Marrink, J. and Hoedemacker, P.J.: The clinical course of IgA nephropathy in adults. Clin. Nephrol. 8: 335–340, (1977).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Egido, J. et al. (1981). New Therapeutic Approach to IgA Mesangial Glomerulonephritis (Berger’s Disease). In: Pavone-Macaluso, M., Smith, P.H., Vercellone, A., Maiorca, R., Rotolo, U. (eds) Advances in Nephrourology. Ettore Majorana International Science Series, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8944-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8944-6_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8946-0
Online ISBN: 978-1-4684-8944-6
eBook Packages: Springer Book Archive